Search Results for: COMBINATION PRODUCTS Device Development for
Articles
Sanofi & MannKind Announce Afrezza, the Only Inhaled Insulin, Now Available in the US February 4, 2015
Sanofi and MannKind Corporation announced today that Afrezza® (insulin human) Inhalation Powder, the only inhaled insulin, is now available by...ICON to Acquire MediMedia Pharma Solutions February 4, 2015
ICON plc recently announced it has agreed, subject to certain customary closing conditions, to acquire MediMedia Pharma Solutions for a...Endo Acquires Company for $2.6 Billion October 21, 2014
Endo International plc and Auxilium Pharmaceuticals, Inc. recently announced they have entered into a definitive agreement under which Endo will...West Pharmaceutical Services & HealthPrize Technologies Join Forces October 7, 2014
West Pharmaceutical Services, Inc. and HealthPrize Technologies, LLC recently announced a strategic collaboration to integrate HealthPrize’s Software-as-a-Service (SaaS) medication adherence...PREFILLED SYRINGE STERILIZATION - NO2 Sterilization: A Flexible Solution for Prefilled Syringes October 6, 2014
Evan Goulet, PhD, and Elizabeth Robbins report on the Noxilizer RTS 360 Industrial NO2 Sterilizer that provides surface sterilization of prefilled syringes with a range of material compatibility and low levels of residuals using its rapid, room-temperature process.
Implementing Innovations in Injectable Drug Delivery With the User & Pharmaceutical Manufacturer in Mind September 23, 2014
By: John A. Merhige, Chief Commercial Officer, and Dan Thayer, Technology Director, Credence MedSystems, Inc. The Current Climate Change is...Foster Delivery Science to Build New Facility; Supports Increased Demand September 22, 2014
Foster Delivery Science has recently broken ground on a new facility to support increased demand for manufacturing drug delivery and...EXECUTIVE INTERVIEW - Foster Delivery Science: Unmatched History & Uncompromising Focus in Hot-Melt Extrusion September 2, 2014
Drug Development Executive: Larry Acquarulo, CEO of Foster Corporation, talks about the history of Foster Delivery Science, their highly focused strategy in melt extrusion, and future plans for the business.
Baxter Biologics Facility In Asia, Announces Expansion Plans August 18, 2014
Baxter International Inc. recently announced the formal opening of its first advanced recombinant biologic facility in Singapore, and expansion plans...Seventh Sense Biosystems Closes $16-Million Financing August 18, 2014
Seventh Sense Biosystems, Inc. (7SBio), the pioneering developer of virtually painless blood collection and diagnostic platforms, recently announced a $16-million...Sanofi & MannKind Announce Global Licensing Agreement August 12, 2014
Sanofi and MannKind Corporation recently announced they have entered into a worldwide exclusive licensing agreement for development and commercialization of...EXECUTIVE INTERVIEW - The Integration of Bend Research With Capsugel Dosage Form Solutions (DFS) June 4, 2014
Drug Development Executive: Rod Ray, former Bend Research CEO and now a member of Capsugel’s Scientific and Business Advisory Board, talks about the enhanced capabilities of Capsugel DFS and the advantages offered to companies developing new and/or enhanced medicines.
SPECIAL FEATURE - Prefilled Syringes & Parenteral Contract Manufacturing - Product Differentiation Is Critical May 8, 2014
Contributor Cindy H. Dubin speaks with several of these suppliers and manufacturers about the importance of customization and differentiation as the key to pharma companies staying competitive in the prefilled syringe space.
Prosonix & Mylan Enter Global Licensing Agreement April 22, 2014
Prosonix recently announced it has entered into a global licensing agreement with Mylan Inc. for its leading inhaled respiratory products,...Mystic Pharmaceuticals Receives Patent for Packaging & Delivery Technology April 14, 2014
Mystic Pharmaceuticals, Inc., recently announced it has been granted US Patent No. 8,683,995 Dose Dispensing Containers for its latest innovations...Monitoring Degree of Agglomeration in Aqueous Suspensions Subjected to Various Environmental Conditions by Raman Imaging April 8, 2014
By: Oksana Olkhovyk, Senior Scientist, Gateway Analytical, Gibsonia, PA, USA Outsourcing the development and manufacturing of generic drug products...Novozymes’ VELTIS Technology Used in GlaxoSmithKline Drug Approved in Europe April 7, 2014
Novozymes Biopharma DK A/S recently announced that its albumin-based VELTIS half-life extension technology is being used by GlaxoSmithKline in the...BUCCAL DELIVERY - Dissolvable Film Format Evolves to Buccal Drug Delivery Applications April 1, 2014
Scott D. Barnhart indicates the buccal and sublingual oral mucosa will continue to be an area of growing interest for drug delivery as researchers evaluate ways to improve bioavailability, patient compliance, and product lifecycle beyond tablet and injectable formats.
Novozymes Biopharma Announces Major Collaboration With Janssen March 17, 2014
Novozymes Biopharma, part of Novozymes A/S, a world leader in bioinnovation, has recently announced a collaboration with Janssen Research &...SPECIAL FEATURE- Analytical Testing of Biologics & Biosimilars March 5, 2014
Contributor Cindy H. Dubin talks with some of the leading experts in the industry about the importance of outsourcing analytical testing in the biologic/biosimilar space, the associated challenges, and how to ensure products get to market safely and quickly.
WHITEPAPER - Addressing Regulatory Challenges for Ophthalmic Combination Products
Going forward, sponsors developing ophthalmic products formulated for delivery as eye drops must be prepared to pursue development programs that address the regulatory requirements for drug-device combination products. Partnering with a contract manufacturing organization (CMO) that has experience bringing such products to market is essential…..
